13F

Stock

Tg Therapeutics, Inc.

TGTX · held by 5 managers

Reported value

$22.4M

Holders

5

+1 new · −0 exited

Holders’ est. mark

−$871.9K

Price effect on 4 books still in the name

Largest holder

$22.3M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC620.5K$22.3M−$870.6KAdded$12.4M
Leonteq Securities AG1.34K$48.2K−$436Added$43.1K
DANSKE BANK A/S700$25.2K−$688Added$17.3K
ELEVATION POINT WEALTH PARTNERS, LLC570$20.5KNew
Prestige Wealth Management Group LLC50$1.8K−$172Cut−$172

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.